The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF
NCT03082885
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Liver Failure
Interventions
DRUG:
Thymosin-α1
Sponsor
Sun Yat-sen University